2nd Edition of Cell & Gene Therapy World Conference(CGTWC) 2026

Scientific Sessions

Targeting Rare Genetic Diseases with Gene Therapy

At the Cell & Gene Therapy World Conference 2026, a key session will focus on the potential of gene therapy to target rare genetic diseases. Experts will discuss groundbreaking advancements in gene editing technologies to address conditions with limited treatment options. Topics will include innovative therapies, challenges in developing treatments for rare diseases, and strategies to make these therapies accessible to patients globally. This session will highlight how gene therapy is revolutionizing the treatment of rare genetic disorders, offering hope to many underserved patient populations.

Related Sessions

CRISPR Cas9 and Beyond: Emerging Genome Editing Platforms
Precision Genome Editing: From Target Discovery to Clinical Application
Engineering the Immune System: Gene and Cell Based Modulation
Non Viral Gene Delivery Strategies: Safety, Scalability, and Translation
Stem Cell Derived Therapeutics: iPSCs, Organoids and Tissue Engineering
Allogeneic vs Autologous Cell Therapies: Manufacturing, Efficacy, and Access
Manufacturing for Personalized Medicine: Customised Cell Products at Scale
Analytics, Potency Assays, and Rapid Release Strategies
CGTs for Monogenic Disorders: Delivering the Cure
Gene and Cell Therapies in Oncology: CAR T, NK, TCR, Oncolytic Approaches
Neurological and Neurodegenerative Disease Applications of CGTs
Market Access, Health Economics, and Reimbursement in CGT
Global Access and Equity: Bridging the CGT Innovation Gap
The Future Landscape of Cell and Gene Therapies: 2030 and Beyond
Cell and Gene Therapy Clinical Development
Cell and Gene Therapy Pipeline Analysis